# Neoadjuvant Immunotherapy in Advanced NSCLC

> **NCT05137912** · — · UNKNOWN · sponsor: **Power Life Sciences Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Lung Cancer, Non-small Cell

## Interventions

- **BIOLOGICAL:** Immunotherapy

## Key facts

- **NCT ID:** NCT05137912
- **Lead sponsor:** Power Life Sciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05137912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05137912, "Neoadjuvant Immunotherapy in Advanced NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05137912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*